Anna Pannaccione | Cellular Neuroscience | Innovative Research Award

Published on by Neuroscientists

Prof. Anna Pannaccione | Cellular Neuroscience | Innovative Research Award

Prof. Anna Pannaccione | University of Naples Federico II | Italy

Anna Pannaccione is Professor of Pharmacology at the University of Naples Federico II, specializing in the molecular mechanisms of neurodegeneration in Alzheimer’s disease. Her research focuses on ionic homeostasis dysregulation, particularly the electrophysiology of voltage-gated K⁺ and Na⁺ channels and Na⁺/Ca²⁺ exchangers (NCX1–3). She investigates the effects of Aβ oligomers on neuronal ionic balance using in vitro and in vivo models, integrating electrophysiology, biochemistry, microscopy, and live-cell imaging. A Principal Investigator in multidisciplinary collaborations, she has authored 75 indexed publications, with 2,613 citations and an h-index of 30, contributing significantly to innovative therapeutic strategies.

Citation Metrics (Scopus)

4000
3000
2000
1000
0

Citations
2613

Documents
75

h-index
30

Citations

Documents

h-index

View Scopus Profile View Orcid Profile

Featured Publications

Rashmi Roy | Cellular Neuroscience | Women Researcher Award

Published on by Neuroscientists

Dr. Rashmi Roy | Cellular Neuroscience | Women Researcher Award

Dr. Rashmi Roy | Madanapalle Institute of Technology & Science | India

Dr. Rashmi Roy is an accomplished scientific leader and Assistant Professor with more than seven years of experience spanning organic chemistry, carbohydrate chemistry, biopolymers, medicinal chemistry, and drug discovery, with a strong record of contributing to both academic and industrial research environments. She is a Fellow of the Indian Chemical Society and a recipient of the Young Scientist Award, reflecting her recognized impact in the chemical sciences. Her research profile includes 9 scholarly documents, which have collectively received 250 citations across 229 citing publications, with an h-index of 5, demonstrating consistent influence and visibility within the scientific community. Dr. Roy has held key roles in academia, pharmaceutical research organizations, and international research institutions, where she has contributed to organic synthesis, project development, and translational research initiatives. She brings a rare interdisciplinary blend of deep scientific expertise and business-oriented competencies, including project strategy, business development, managerial economics, and international collaboration. Her work is complemented by strong skills in scientific writing, environmental sciences, and innovation management, enabling her to bridge laboratory research with organizational growth objectives. Known for her effective communication and leadership abilities, she has actively engaged in knowledge dissemination through lectures and conference presentations. Dr. Roy continues to focus on advancing research-driven innovation while contributing to strategic development within research-focused organizations.

Citation Metrics (Scopus)

400
300
200
100
0

Citations
250

Documents
9

h-index
5

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile View Orcid Profile

Featured Publication

Caterina Miro | Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Caterina Miro | Cellular Neuroscience | Best Researcher Award

Dr. Caterina MIRO,  Department of Clinical Medicine and Surgery, University of Naples Federico II, Italy.

Dr. Caterina Miro is a dedicated and accomplished Italian biomedical researcher specializing in thyroid hormone signaling, molecular oncology, and metabolic reprogramming in cancer and systemic diseases. With a Ph.D. awarded with honors in “Newer Biomedical and Surgical Treatments” and multiple postdoctoral fellowships at the University of Naples “Federico II,” her work consistently bridges the gap between molecular biology and translational medicine. Her research focuses on unraveling the roles of thyroid hormones in tumor progression, chemoresistance, and metabolic dysfunctions, with notable projects funded by premier institutions such as AIRC and Fondazione Veronesi. Dr. Miro has gained recognition for her contributions to endocrine oncology and her growing influence in the academic community.

Profile

Orcid

 

🎓 Early Academic Pursuits

Born on October 23, 1987, in Avellino, Italy, Dr. Caterina Miro’s scientific path began with an early passion for biological sciences. After completing her high school education with distinction (95/100) at the “P.E. Imbriani” Scientific High School, she enrolled at the University of Naples “Federico II,” where she earned both her Bachelor’s and Master’s degrees in Biological Sciences. Her Master’s thesis, which earned a full score of 110/110 cum laude, focused on innovative therapeutic strategies in reactivating tumor suppressor pathways in malignant pleural mesothelioma. Under the mentorship of Prof. Paolo Laccetti and Dr. Francesca Pentimalli, she laid the foundation for a career centered on molecular oncology and translational medicine.

🧪 Professional Endeavors in Biomedical Research

Dr. Miro’s journey into advanced research began with her early involvement in experimental oncology, particularly during her fellowship at the National Cancer Institute “G. Pascale” and IEOS-CNR Naples. From 2015 onwards, she transitioned into focused roles within the Department of Clinical Medicine and Surgery at the University of Naples “Federico II.” Here, she held several key postdoctoral positions, consistently contributing to endocrine oncology and molecular biology research under the guidance of eminent mentors such as Prof. Domenico Salvatore and Prof. Monica Dentice. Her Ph.D. in “Newer Biomedical and Surgical Treatments,” awarded with excellent with honours, further solidified her place in the realm of academic medicine.

🧬 Contributions and Research Focus

The central axis of Dr. Miro’s research revolves around thyroid hormone metabolism and its role in cancer biology and systemic diseases. Her work delves into the genomic and non-genomic effects of thyroid hormones in squamous cell carcinomas, the metabolic reprogramming in obesity, and the interaction between thyroid pathways and muscular dystrophy. Notably, her recent projects funded by prestigious institutions such as AIRC and Fondazione Veronesi address critical questions in the tumor microenvironment, hormone-driven chemoresistance, and endocrine-metabolic cross-talk. Her methodical approach bridges molecular endocrinology with translational cancer therapeutics, paving the way for targeted interventions.

🏅 Accolades and Recognition

Dr. Miro’s academic and research distinction is evident in the highly competitive fellowships and grants she has secured. Among them, the AIRC-funded postdoctoral fellowship (2025–2027) and the Fondazione Veronesi Research Grant (2024–2025) stand out as acknowledgments of her scientific caliber and project innovation. She has consistently earned positions in merit-based fellowships and has been entrusted with executing pivotal roles in nationally and internationally funded research initiatives. Her Ph.D. distinction, cum laude degree, and continued appointments at Italy’s leading medical university further underscore her credibility in the academic and biomedical community.

🧠 Impact and Influence in Molecular Endocrinology

The influence of Dr. Miro’s work extends beyond laboratory findings. By elucidating the stage-specific roles of thyroid hormone in cancer, she has contributed to a better understanding of how endocrine signals shape tumor behavior and progression. Her research also explores new molecular targets for combating chemoresistance and improving therapeutic responses in skin and lung cancers. These contributions not only enrich the scientific literature but also inform clinical strategies and drug development efforts. Her work bridges a crucial gap between metabolic signaling and cancer therapeutics, enhancing the translational potential of endocrine research.

🌍 Legacy and Future Contributions

Looking ahead, Dr. Miro is poised to become a leading voice in the intersection of endocrinology and oncology. Her evolving portfolio—ranging from thyroid hormone function in obesity to Sirtuin-mediated muscular disorders—demonstrates a vision that spans both depth and breadth. As she continues to harness hormone pathways for therapeutic insights, her interdisciplinary collaborations and methodical precision are expected to yield influential results. Her ongoing commitment to mentorship and academic engagement ensures her legacy will extend into nurturing the next generation of biomedical researchers.

🔬 Vision for Integrative Cancer Therapy

At the core of Dr. Miro’s research philosophy is a dedication to integrative approaches in cancer therapy. She envisions a therapeutic landscape where thyroid hormone pathways are not only understood but also manipulated for patient-specific interventions. Her recent investigations into metabolic reprogramming within the tumor microenvironment reflect a shift towards holistic and multi-layered treatment modalities. Through advanced molecular techniques and translational applications, she continues to push the boundaries of how endocrine signals can be decoded and redirected to combat complex diseases like cancer, muscular dystrophy, and systemic metabolic disorders.

Publication

Title: Ursolic Acid-Based Nutraceutical Mitigates Muscle Atrophy and Improves Exercise Performance in Mouse Model of Peripheral Neuropathy
Authors: Caterina Miro, Fortuna Iannuzzo, Lucia Acampora, Annunziata Gaetana Cicatiello, Serena Sagliocchi, Elisabetta Schiano, Annarita Nappi, Federica Restolfer, Mariano Stornaiuolo, Gian Carlo Tenore, et al.
Year: 2025

Title: Leptin enhances the intracellular thyroid hormone activation in skeletal muscle to boost energy balance
Authors: Miro C, Cicatiello AG, Nappi A, Sagliocchi S, Acampora L, Restolfer F, Cuomo O, de Alteris G, Pugliese G, Torabinejad S, et al.
Year: 2025

Title: Muscle PGC‐1α Overexpression Drives Metabolite Secretion Boosting Subcutaneous Adipocyte Browning
Authors: Caterina Miro, Ciro Menale, Lucia Acampora, Annarita Nappi, Serena Sagliocchi, Federica Restolfer, Sepehr Torabinejad, Mariano Stornaiuolo, Monica Dentice, Annunziata Gaetana Cicatiello
Year: 2025

Title: Thyroid Hormone Activation Regulates the Crosstalk between Breast Cancer and Mesenchymal Stem Cells
Authors: Annarita Nappi, Vittoria D’Esposito, Caterina Miro, Alessia Parascandolo, Annunziata Gaetana Cicatiello, Serena Sagliocchi, Lucia Acampora, Sepehr Torabinejad, Federica Restolfer, Maddalena Raia, et al.
Year: 2025

Title: AbaComplex Enhances Mitochondrial Biogenesis and Adipose Tissue Browning: Implications for Obesity and Glucose Regulation
Authors: Serena Sagliocchi, Elisabetta Schiano, Lucia Acampora, Fortuna Iannuzzo, Annunziata Gaetana Cicatiello, Caterina Miro, Annarita Nappi, Federica Restolfer, Mariano Stornaiuolo, Stefano Zarrilli, et al.
Year: 2024

Title: Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays
Authors: Francesco Piacente, Giorgia Guccione, Naomi Scarano, Dario Lunaccio, Caterina Miro, Elena Abbotto, Annalisa Salis, Bruno Tasso, Monica Dentice, Santina Bruzzone, et al.
Year: 2024

Title: Effects of thyroid hormones in skeletal muscle protein turnover
Authors: Annarita Nappi, Caterina Moriello, Maria Morgante, Ferdinando Fusco, Felice Crocetto, Caterina Miro
Year: 2024

Title: Therapeutic Effect of an Ursolic Acid-Based Nutraceutical on Neuronal Regeneration after Sciatic Nerve Injury
Authors: Fortuna Iannuzzo, Annunziata Gaetana Cicatiello, Serena Sagliocchi, Elisabetta Schiano, Annarita Nappi, Caterina Miro, Mariano Stornaiuolo, Adriano Mollica, Gian Carlo Tenore, Monica Dentice, et al.
Year: 2024

Title: Repositioning of Cefuroxime as novel selective inhibitor of the thyroid hormone activating enzyme type 2 deiodinase
Authors: Sagliocchi S, Murolo M, Cicatiello AG, Miro C, Nappi A, Di Cicco E, Torabinejad S, La Civita E, Romano V, Terracciano D, et al.
Year: 2023

Title: SIRT6 pharmacological inhibition delays skin cancer progression in the squamous cell carcinoma
Authors: Elena Abbotto, Caterina Miro, Francesco Piacente, Annalisa Salis, Melania Murolo, Annarita Nappi, Enrico Millo, Eleonora Russo, Elena Cichero, Laura Sturla, et al.
Year: 2023

Conclusion

Dr. Miro’s scientific journey reflects a rare combination of academic excellence, innovation, and translational impact. Through her deep exploration of hormone-driven mechanisms in cancer and other complex diseases, she has significantly advanced our understanding of molecular endocrinology. Her trajectory suggests she is not only a valuable contributor to ongoing biomedical research but also a future leader in the development of integrative therapeutic strategies. With sustained support and collaborative opportunities, Dr. Caterina Miro is poised to make lasting contributions to personalized medicine and targeted cancer therapy in the years ahead.

 

Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Published on by Neuroscientists

Dr. Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Dr. Ketan Bulsara, University of Connecticut, United States.

Dr. Ketan Ramanlal Bulsara is a distinguished neurosurgeon, educator, and administrator whose career has been defined by excellence in academic leadership, innovative research, and patient-centered surgical advancements. With a strong foundation in medical education and training, he has held prestigious positions at leading institutions, making significant contributions to the fields of cerebrovascular and skull base surgery. His work in neurosurgical education, healthcare policy, and perioperative quality improvement continues to influence the next generation of medical professionals.

Profile

Google Scholar

 

🎓 Early Academic Pursuits: The Foundation of Excellence

Dr. Ketan Ramanlal Bulsara’s journey into the world of neurosurgery began with a strong academic foundation. He earned his Bachelor of Science in Biology and Neuroscience, graduating Magna Cum Laude from Davidson College in 1992. His passion for medicine led him to Duke University School of Medicine, where he earned his Medical Degree with Honors in 1996. Committed to mastering his craft, Dr. Bulsara underwent rigorous neurosurgical training at Duke University Medical Center, progressing through internship, residency, and chief residency roles. His dedication to specialized knowledge took him to the University of Iowa for a fellowship in Transoral Surgery and later to Duke’s Neurovascular Program for an advanced Endovascular Fellowship, earning CAST certification by the Senior Neurological Society.

🎉 Professional Endeavors: Pioneering Neurosurgical Excellence

Dr. Bulsara has held esteemed academic and leadership positions throughout his career. Beginning as an Assistant Professor at the University of Missouri, he quickly ascended to directorship roles at Yale University, where he led Neuroendovascular and Skull Base Surgery Programs. His expertise and leadership took him to UConn Health, where he has served as Professor and Chief of Neurosurgery since 2017. As Program Director of UConn’s Neurosurgery Residency Training Program and Director of Operating Room Quality, he has been instrumental in shaping the next generation of neurosurgeons. His administrative impact extended further when he was appointed Interim Inaugural Chairman of UConn’s Department of Neurosurgery in 2024.

📚 Contributions and Research Focus: Advancing Neurosurgical Innovation

Throughout his career, Dr. Bulsara has been at the forefront of neurosurgical research, focusing on cerebrovascular and skull base surgery, neuroendovascular techniques, and perioperative advancements. His tenure at Yale and UConn Health has been marked by groundbreaking contributions to neurosurgical methodologies, patient safety protocols, and cutting-edge surgical interventions. With a keen interest in medical policy and administration, he also serves as Chair of the UConn Health/University of Connecticut Dean’s Task Force on Coding and Documentation, ensuring optimal standards in medical practice.

🏆 Accolades and Recognition: A Trailblazer’s Achievements

Dr. Bulsara’s exemplary work has earned him widespread recognition in academic, clinical, and administrative spheres. His leadership has been pivotal in strengthening neurosurgical departments and residency programs, earning respect from peers and students alike. His continued commitment to excellence led him to pursue an Executive MBA at Yale School of Management, which he completed in 2017, equipping him with advanced skills in healthcare management and strategic planning. Furthering his multidisciplinary expertise, he embarked on a legal education at the University of Connecticut School of Law in 2024, highlighting his commitment to integrating medicine, business, and law for the betterment of healthcare.

💡 Impact and Influence: Shaping the Future of Neurosurgery

Dr. Bulsara’s influence extends far beyond the operating room. As a mentor, he has trained and guided numerous neurosurgeons, instilling in them the values of precision, innovation, and patient-centered care. His research and administrative contributions have shaped hospital policies and perioperative strategies, leading to improved surgical outcomes and enhanced healthcare delivery systems. His work in academic leadership continues to bridge the gap between medical practice, research, and education.

 

Publication

  • Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons – HM Bomze, KR Bulsara, BJ Iskandar, P Caroni, JH Pate Skene (2001)

 

  • Longitudinal molecular trajectories of diffuse glioma in adults – FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, et al. (2019)

 

  • Glioma progression is shaped by genetic evolution and microenvironment interactions – FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, et al. (2022)

 

  • Accuracy of prediction instruments for diagnosing large vessel occlusion in individuals with suspected stroke: a systematic review for the 2018 guidelines for the early… – EE Smith, DM Kent, KR Bulsara, LY Leung, JH Lichtman, MJ Reeves, et al. (2018)

 

  • Perioperative complications in transforaminal lumbar interbody fusion versus anterior–posterior reconstruction for lumbar disc degeneration and instability – AT Villavicencio, S Burneikiene, KR Bulsara, JJ Thramann (2006)

 

  • Vessel wall magnetic resonance imaging identifies the site of rupture in patients with multiple intracranial aneurysms: proof of principle – CC Matouk, DM Mandell, M Günel, KR Bulsara, A Malhotra, R Hebert, et al. (2013)

 

  • Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein—2 – AT Villavicencio, S Burneikiene, EL Nelson, KR Bulsara, M Favors, et al. (2005)

 

  • Laminectomy versus percutaneous electrode placement for spinal cord stimulation – AT Villavicencio, JC Leveque, L Rubin, K Bulsara, JP Gorecki (2000)

 

  • Indications for thrombectomy in acute ischemic stroke from emergent large vessel occlusion (ELVO): report of the SNIS Standards and Guidelines Committee – M Mokin, SA Ansari, RA McTaggart, KR Bulsara, M Goyal, M Chen, et al. (2019)

 

  • Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy – SM Nimjee, CJ Powers, KR Bulsara (2006)

 

💪 Conclusion

A visionary in neurosurgery, Dr. Bulsara’s impact transcends surgical practice, reaching into medical education, research, and healthcare administration. His multidisciplinary approach—combining medicine, business, and law—positions him as a leader in shaping the future of healthcare. His commitment to innovation and excellence ensures that his contributions will continue to elevate neurosurgical standards and inspire future generations of medical professionals.